Literature DB >> 10385552

Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables.

A P Pinto1, L B Signorello, C P Crum, B L Harlow, F Abrão, L L Villa.   

Abstract

BACKGROUND: Certain clinicopathologic features of vulvar squamous cell carcinoma have been correlated with adverse prognosis. However, few large-scale studies have addressed their role in patient survival. This study examined the relationship between multiple variables and prognosis in a large group of vulvar cancers in Brazil.
METHODS: One hundred eighty-four Brazilian women with vulvar carcinoma were studied and the following variables recorded: age, pathologic TNM stage, survival, histologic grade, tumor histologic pattern, invasion pattern, tumor thickness, and tissue stromal and inflammatory response. Human papillomavirus (HPV) was detected by polymerase chain reaction amplification of extracted archival DNA. Data were analyzed using Cox proportional hazards modeling.
RESULTS: After controlling for age, the probability of cancer survival decreased with increasing age, stage, grade, and tumor thickness, a fibromyxoid stromal response, infiltrative growth pattern, and basaloid histologic pattern. With the exception of fibromyxoid stromal response, each of these variables remained prognostically significant after adjustment for several other predictors in a multivariate model. Women whose tumors displayed a basaloid pattern were 3.5 times as likely to die from cancer than those with keratinizing tumors [hazard ratio (HR) = 3.5, 95% CI(1.3-9.2)]. An infiltrative invasion pattern strongly increased the probability of cancer death [HR = 4.6, 95% CI(1.9,11.4)]. HPV status did not influence survival, despite its association with basaloid histology.
CONCLUSIONS: Previously reported associations of negative HPV status and fibromyxoid response with adverse prognosis in vulvar cancer were not confirmed by multivariate analysis. Basaloid variants, and particularly diffusely infiltrative tumors, carry an adverse prognosis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10385552     DOI: 10.1006/gyno.1999.5458

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  A fibromyxoid stromal response is associated with an infiltrative tumor morphology, perineural invasion, and lymph node metastasis in squamous cell carcinoma of the vulva.

Authors:  Susanne K Jeffus; Ashita Gehlot; Emily Holthoff; Rebecca Stone; Horace Spencer; Thomas Kelly; Steven R Post; Charles M Quick
Journal:  Am J Surg Pathol       Date:  2015-09       Impact factor: 6.394

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Pathologic features of aggressive vulvar carcinoma are associated with epithelial-mesenchymal transition.

Authors:  Emily R Holthoff; Horace Spencer; Thomas Kelly; Steven R Post; Charles M Quick
Journal:  Hum Pathol       Date:  2016-06-18       Impact factor: 3.466

4.  Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva.

Authors:  Mauricio Cordoni Nogueira; Ernesto de Paula Guedes Neto; Marcos Wengrover Rosa; Eduardo Zettler; Cláudio Galleano Zettler
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

5.  Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction.

Authors:  Julia W Gargano; Edward J Wilkinson; Elizabeth R Unger; Martin Steinau; Meg Watson; Youjie Huang; Glenn Copeland; Wendy Cozen; Marc T Goodman; Claudia Hopenhayn; Charles F Lynch; Brenda Y Hernandez; Edward S Peters; Maria Sibug Saber; Christopher W Lyu; Lauren A Sands; Mona Saraiya
Journal:  J Low Genit Tract Dis       Date:  2012-10       Impact factor: 1.925

6.  The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.

Authors:  Jacek J Sznurkowski; Anton Żawrocki; Wojciech Biernat
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.